Sharp Daily
No Result
View All Result
Thursday, June 5, 2025
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
Sharp Daily
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
No Result
View All Result
Sharp Daily
No Result
View All Result
Home News

Pharmacy and Poisons Board orders nationwide recall of Tamedol medication

Brian Murimi by Brian Murimi
September 20, 2023
in News
Reading Time: 2 mins read

The Pharmacy and Poisons Board (PPB) has ordered a mandatory nationwide recall of the pain relief medication Tamedol oral solution after discovering quality issues with several batches of the product, the regulatory agency announced Tuesday.

The PPB said its investigation found numerous batches of the paracetamol-based medication manufactured by Biopharma LTD failed to meet required quality standards.

“In response to these concerns, the PPB upon investigations, indeed confirmed that the product FAILED to meet the prescribed market authorization requirements and has initiated mandatory recall of the product by the manufacturer,” the agency said in a statement.

Read more:Ukraine and Kenya forge deal on new grain export hubs

RELATEDPOSTS

Pharmacy board clears Mefenamic Acid suspension for market distribution

March 18, 2025

Pharmacy and poisons board issues advisory on safe handling of health products

March 12, 2025

PPB Chief Executive Officer Dr. F.M. Siyoi said the recall aims “to guarantee that medicines supplied to the Kenyan market adhere to the requisite standards of quality, safety and efficacy.”

The agency advised all pharmacies, healthcare facilities, medical professionals and consumers to immediately quarantine any remaining stock of the recalled product and return it to suppliers or healthcare facilities.

Members of the public who have questions or concerns about the recall can contact the PPB through its website, mobile app, email or a dedicated telephone line, the agency said.

Siyoi encouraged consumers to remain alert about medication safety. “We encourage the public to remain vigilant at all times and promptly report any suspected cases of sub-standard medicines or adverse drug reactions,” he said.

The PPB regulates the manufacture, importation, exportation, distribution and use of pharmaceutical products in Kenya.

Email your news TIPS to editor@thesharpdaily.com

Previous Post

Ukraine and Kenya forge deal on new grain export hubs

Next Post

Ruto urges global mobilization for Sustainable Development Goals

Brian Murimi

Brian Murimi

Brian Murimi is a journalist with major interests in covering tech, corporates, startups and business news. When he's not writing, you can find him gaming, watching football or sipping a nice cup of tea. Send tips via bireri@thesharpdaily.com

Related Posts

News

Co-op Bank posts KES 6.9 billion profit in Q1’2025

May 16, 2025
Agriculture And Economy
News

Lets get Kenya out of FATF list

May 9, 2025
News

The downside of Impact Investing

May 2, 2025
News

Leadership challenges at the University of Nairobi

April 24, 2025
News

Easter eggs and earnings: Growing your nest egg with CMMF

April 16, 2025
News

Geoffrey Ruku declares KES 377M net worth during CS vetting

April 15, 2025

LATEST STORIES

How Kenyan banks can modernize without marginalizing

June 4, 2025

Human rights concerns over activists’ treatment in Tanzania

June 4, 2025

Decoding stock-based compensation

June 4, 2025

Comparative advantage is the secret to real economic take off

June 4, 2025

Understanding inflation and its impact on everyday life

June 4, 2025

Economic reforms are costly

June 3, 2025

Cytonn Income Drawdown Fund (CIDDF)

June 3, 2025

Navigating the money market and fixed income funds landscape

June 3, 2025
  • About Us
  • Meet The Team
  • Careers
  • Privacy Policy
  • Terms and Conditions
Email us: editor@thesharpdaily.com

Sharp Daily © 2024

No Result
View All Result
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team

Sharp Daily © 2024